Teladoc Health (NYSE:TDOC - Free Report) had its target price trimmed by Bank of America from $8.00 to $7.00 in a research report released on Wednesday morning,Benzinga reports. The brokerage currently has a neutral rating on the health services provider's stock.
Several other research firms have also issued reports on TDOC. Jefferies Financial Group reduced their target price on Teladoc Health from $10.00 to $8.00 and set a "hold" rating on the stock in a report on Monday, April 21st. Piper Sandler reduced their target price on Teladoc Health from $13.00 to $12.00 and set an "overweight" rating on the stock in a report on Thursday, February 27th. The Goldman Sachs Group reduced their target price on Teladoc Health from $13.00 to $10.00 and set a "buy" rating on the stock in a report on Thursday, May 1st. Stifel Nicolaus reduced their target price on Teladoc Health from $9.00 to $8.00 and set a "hold" rating on the stock in a report on Thursday, May 1st. Finally, Needham & Company LLC reissued a "hold" rating on shares of Teladoc Health in a report on Thursday, May 1st. Twelve equities research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of "Hold" and an average target price of $9.60.
Check Out Our Latest Analysis on Teladoc Health
Teladoc Health Stock Performance
NYSE TDOC traded down $0.06 on Wednesday, reaching $6.92. The stock had a trading volume of 6,253,823 shares, compared to its average volume of 6,265,428. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.73 and a quick ratio of 1.69. The firm has a fifty day moving average of $7.26 and a two-hundred day moving average of $9.20. Teladoc Health has a 1-year low of $6.35 and a 1-year high of $15.21. The company has a market cap of $1.21 billion, a P/E ratio of -1.20 and a beta of 1.82.
Teladoc Health (NYSE:TDOC - Get Free Report) last issued its quarterly earnings data on Wednesday, February 26th. The health services provider reported ($0.28) EPS for the quarter, missing analysts' consensus estimates of ($0.21) by ($0.07). The firm had revenue of $640.49 million during the quarter, compared to analyst estimates of $639.44 million. Teladoc Health had a negative net margin of 37.91% and a negative return on equity of 10.06%. On average, equities research analysts anticipate that Teladoc Health will post -1.16 EPS for the current year.
Insider Buying and Selling at Teladoc Health
In other news, insider Adam C. Vandervoort sold 11,011 shares of the firm's stock in a transaction dated Thursday, March 20th. The stock was sold at an average price of $8.42, for a total transaction of $92,712.62. Following the completion of the transaction, the insider now directly owns 64,308 shares in the company, valued at $541,473.36. This trade represents a 14.62% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Corporate insiders own 0.58% of the company's stock.
Hedge Funds Weigh In On Teladoc Health
A number of hedge funds have recently made changes to their positions in the stock. KBC Group NV grew its stake in Teladoc Health by 72.3% during the fourth quarter. KBC Group NV now owns 8,849 shares of the health services provider's stock worth $80,000 after purchasing an additional 3,714 shares during the period. Robeco Institutional Asset Management B.V. grew its stake in Teladoc Health by 21.8% during the fourth quarter. Robeco Institutional Asset Management B.V. now owns 700,166 shares of the health services provider's stock worth $6,365,000 after purchasing an additional 125,111 shares during the period. Murphy Pohlad Asset Management LLC acquired a new stake in Teladoc Health during the fourth quarter worth approximately $458,000. Summit Trail Advisors LLC acquired a new stake in Teladoc Health during the fourth quarter worth approximately $92,000. Finally, Allspring Global Investments Holdings LLC acquired a new stake in Teladoc Health during the fourth quarter worth approximately $2,859,000. 76.82% of the stock is currently owned by institutional investors.
Teladoc Health Company Profile
(
Get Free Report)
Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.
See Also
Before you consider Teladoc Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Teladoc Health wasn't on the list.
While Teladoc Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
